Sanofi

Sanofi Oncology is a global leader in the research and development of innovative cancer therapies. The division focuses on a diverse range of cancer types and stages, employing extensive expertise to address the varying needs of patients. Sanofi's oncology portfolio includes treatments for conditions such as metastatic cutaneous squamous cell carcinoma and various hematologic malignancies, among others. The company is committed to advancing cancer treatment through drug discovery, translational research, and preclinical studies, utilizing cutting-edge methodologies in signal transduction and molecular receptor chemistry. With a strong emphasis on patient-centric solutions, Sanofi Oncology aims to create long-term value by delivering effective therapies tailored to the complexities of cancer care.